Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Rabies
Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou
May 7th, 2008
A project for producing inactivated rabies animal vaccines was recently launched in Changzhou National High-tech District, east China's Jiangsu Province. This is a new product developed by a team of leading overseas scientists. It is reported that it is the first time for China will produce this kind of high-tech inactivated vaccine. This vaccine is expected to replace less effective attenuated rabies living vaccines manufactured in China as well as the more expensive imported products. In this project, major products of a newly-founded company, Changzhou Tongtai Biopharmaceutical Co., Ltd., will be produced. The technological team is under the leadership of Fu...
Source: Vaccine Weekly (2008-05-07)
|
